Works by van der Burg, Sjoerd H.


Results: 93
    1
    2
    3
    4
    5

    Long lasting p53-specific T cell memory responses in the absence of anti-p53 antibodies in patients with resected primary colorectal cancer.

    Published in:
    European Journal of Immunology, 2001, v. 31, n. 1, p. 146, doi. 10.1002/1521-4141(200101)31:1<146::AID-IMMU146>3.0.CO;2-T
    By:
    • van der Burg, Sjoerd H.;
    • de Cock, Karin;
    • Menon, Anand G.;
    • Franken, Kees L. M. C;
    • Palmen, Mary;
    • Redeker, Anke;
    • Drijfhout, Jan W.;
    • Kuppen, Peter J. K.;
    • van de Velde, Cornelis J. H.;
    • Erdile, Lorne;
    • Tollenaar, Rob A. E. M.;
    • Melief, Cornelis J. M.;
    • Offringa, Rienk
    Publication type:
    Article
    6
    7
    8
    9
    10
    11
    12

    PROTECT: Prospective Phase-II-Trial Evaluating Adaptive Proton Therapy for Cervical Cancer to Reduce the Impact on Morbidity and the Immune System.

    Published in:
    Cancers, 2021, v. 13, n. 20, p. 5179, doi. 10.3390/cancers13205179
    By:
    • Corbeau, Anouk;
    • Nout, Remi A.;
    • Mens, Jan Willem M.;
    • Horeweg, Nanda;
    • Godart, Jérémy;
    • Kerkhof, Ellen M.;
    • Kuipers, Sander C.;
    • van Poelgeest, Mariette I. E.;
    • Kroep, Judith R.;
    • Boere, Ingrid A.;
    • van Doorn, Helena C.;
    • Hoogeman, Mischa S.;
    • van der Heide, Uulke A.;
    • Putter, Hein;
    • Welters, Marij J. P.;
    • van der Burg, Sjoerd H.;
    • Creutzberg, Carien L.;
    • de Boer, Stephanie M.
    Publication type:
    Article
    13
    14
    15

    HPV16 synthetic long peptide (HPV16-SLP) vaccination therapy of patients with advanced or recurrent HPV16-induced gynecological carcinoma, a phase II trial.

    Published in:
    Journal of Translational Medicine, 2013, v. 11, n. 1, p. 1, doi. 10.1186/1479-5876-11-88
    By:
    • van Poelgeest, Mariette I. E.;
    • Welters, Marij J. P.;
    • van Esch, Edith M. G.;
    • Stynenbosch, Linda F. M.;
    • Kerpershoek, Gijs;
    • van Persijn van Meerten, Els L.;
    • den Hende, Muriel van;
    • Löwik, Margriet J. G.;
    • Berends-van der Meer, Dorien M. A.;
    • Fathers, Lorraine M.;
    • Valentijn, A. Rob P. M.;
    • Oostendorp, Jaap;
    • Fleuren, Gert Jan;
    • Melief, Cornelis J. M.;
    • Kenter, Gemma G.;
    • van der Burg, Sjoerd H.
    Publication type:
    Article
    16

    HPV16 synthetic long peptide (HPV16-SLP) vaccination therapy of patients with advanced or recurrent HPV16-induced gynecological carcinoma, a phase II trial.

    Published in:
    2013
    By:
    • van Poelgeest, Mariette I E;
    • Welters, Marij J P;
    • van Esch, Edith M G;
    • Stynenbosch, Linda F M;
    • Kerpershoek, Gijs;
    • van Persijn van Meerten, Els L;
    • van den Hende, Muriel;
    • Löwik, Margriet J G;
    • Berends-van der Meer, Dorien M A;
    • Fathers, Lorraine M;
    • Valentijn, A Rob P M;
    • Oostendorp, Jaap;
    • Fleuren, Gert Jan;
    • Melief, Cornelis J M;
    • Kenter, Gemma G;
    • van der Burg, Sjoerd H
    Publication type:
    journal article
    17
    18
    19

    Characterization of the early cellular immune response induced by HPV vaccines.

    Published in:
    Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.863164
    By:
    • Pasmans, Hella;
    • Berkowska, Magdalena A.;
    • Diks, Annieck M.;
    • de Mooij, Bas;
    • Groenland, Rick J.;
    • de Rond, Lia;
    • Nicolaie, M. Alina;
    • van der Burg, Sjoerd H.;
    • van Dongen, Jacques J. M.;
    • van der Klis, Fiona R. M.;
    • Buisman, Anne-Marie
    Publication type:
    Article
    20
    21

    Neoantigen-specific immunity in low mutation burden colorectal cancers of the consensus molecular subtype 4.

    Published in:
    Genome Medicine, 2019, v. 11, n. 1, p. 1, doi. 10.1186/s13073-019-0697-8
    By:
    • van den Bulk, Jitske;
    • Verdegaal, Els M. E.;
    • Ruano, Dina;
    • Ijsselsteijn, Marieke E.;
    • Visser, Marten;
    • van der Breggen, Ruud;
    • Duhen, Thomas;
    • van der Ploeg, Manon;
    • de Vries, Natasja L.;
    • Oosting, Jan;
    • Peeters, Koen C. M. J.;
    • Weinberg, Andrew D.;
    • Farina-Sarasqueta, Arantza;
    • van der Burg, Sjoerd H.;
    • de Miranda, Noel F. C. C.
    Publication type:
    Article
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32

    Distinct regulation and impact of type 1 T-cell immunity against HPV16 L1, E2 and E6 antigens during HPV16-induced cervical infection and neoplasia.

    Published in:
    International Journal of Cancer, 2006, v. 118, n. 3, p. 675, doi. 10.1002/ijc.21394
    By:
    • van Poelgeest, Mariëtte I.E.;
    • Nijhuis, Esther R.;
    • Kwappenberg, Kitty M.C.;
    • Hamming, Ineke E.;
    • Wouter Drijfhout, Jan;
    • Fleuren, Gert Jan;
    • van der Zee, Ate G.J.;
    • Melief, Cornelis J.M.;
    • Kenter, Gemma G.;
    • Nijman, Hans W.;
    • Offringa, Rienk;
    • van der Burg, Sjoerd H.
    Publication type:
    Article
    33
    34
    35

    Natural T-helper immunity against human papillomavirus type 16 (hpv16) e7-derived peptide epitopes in patients with hpv16-positive cervical lesions: Identification of 3 human leukocyte antigen class ii-restricted epitopes.

    Published in:
    International Journal of Cancer, 2001, v. 91, n. 5, p. 612, doi. 10.1002/1097-0215(200002)9999:9999<::AID-IJC1119>3.0.CO;2-C
    By:
    • van der Burg, Sjoerd H.;
    • Ressing, Maaike E.;
    • Kwappenberg, Kitty M.C.;
    • de Jong, Annemieke;
    • Straathof, Karin;
    • de Jong, Joan;
    • Geluk, Annemieke;
    • van Meijgaarden, Krista E.;
    • Franken, Kees L.M.C.;
    • Ottenhoff, Tom H.M.;
    • Fleuren, Gert Jan;
    • Kenter, Gemma;
    • Melief, Cornelis J.M.;
    • Offringa, Rienk
    Publication type:
    Article
    36
    37

    Harmonization of Immune Biomarker Assays for Clinical Studies.

    Published in:
    Science Translational Medicine, 2011, v. 3, n. 108, p. 1, doi. 10.1126/scitranslmed.3002785
    By:
    • van der Burg, Sjoerd H.;
    • Kalos, Michael;
    • Gouttefangeas, Cécile;
    • Janetzki, Sylvia;
    • Ottensmeier, Christian;
    • Welters, Marij J. P.;
    • Romero, Pedro;
    • Britten, Cedrik M.;
    • Hoos, Axel
    Publication type:
    Article
    38
    39
    40

    NKG2A is a late immune checkpoint on CD8 T cells and marks repeated stimulation and cell division.

    Published in:
    International Journal of Cancer, 2022, v. 150, n. 4, p. 688, doi. 10.1002/ijc.33859
    By:
    • Borst, Linda;
    • Sluijter, Marjolein;
    • Sturm, Gregor;
    • Charoentong, Pornpimol;
    • Santegoets, Saskia J.;
    • van Gulijk, Mandy;
    • van Elsas, Marit J.;
    • Groeneveldt, Christianne;
    • van Montfoort, Nadine;
    • Finotello, Francesca;
    • Trajanoski, Zlatko;
    • Kiełbasa, Szymon M.;
    • van der Burg, Sjoerd H.;
    • van Hall, Thorbald
    Publication type:
    Article
    41
    42
    43
    44
    45

    p53: A Potential Target Antigen for Immunotherapy of Cancer.

    Published in:
    Annals of the New York Academy of Sciences, 2000, v. 910, n. 1, p. 223, doi. 10.1111/j.1749-6632.2000.tb06711.x
    By:
    • OFFRINGA, RIENK;
    • VIERBOOM, MICHEL P. M.;
    • VAN DER BURG, SJOERD H.;
    • ERDILE, LORNE;
    • MELIEF, CORNELIS J. M.
    Publication type:
    Article
    46

    PD-L1 checkpoint blockade promotes regulatory T cell activity that underlies therapy resistance.

    Published in:
    Science Immunology, 2023, v. 8, n. 83, p. 1, doi. 10.1126/sciimmunol.abn6173
    By:
    • van Gulijk, Mandy;
    • van Krimpen, Anneloes;
    • Schetters, Sjoerd;
    • Eterman, Mike;
    • van Elsas, Marit;
    • Mankor, Joanne;
    • Klaase, Larissa;
    • de Bruijn, Marjolein;
    • van Nimwegen, Menno;
    • van Tienhoven, Tim;
    • van Ijcken, Wilfred;
    • Boon, Louis;
    • van der Schoot, Johan;
    • Verdoes, Martijn;
    • Scheeren, Ferenc;
    • van der Burg, Sjoerd H.;
    • Lambrecht, Bart N.;
    • Stadhouders, Ralph;
    • Dammeijer, Floris;
    • Aerts, Joachim
    Publication type:
    Article
    47
    48
    49
    50

    Vaccination during myeloid cell depletion by cancer chemotherapy fosters robust T cell responses.

    Published in:
    Science Translational Medicine, 2016, v. 8, n. 334, p. 1, doi. 10.1126/scitranslmed.aad8307
    By:
    • Welters, Marij J.;
    • van der Sluis, Tetje C.;
    • van Meir, Hélène;
    • Loof, Nikki M.;
    • van Ham, Vanessa J.;
    • van Duikeren, Suzanne;
    • Santegoets, Saskia J.;
    • Arens, Ramon;
    • de Kam, Marieke L.;
    • Cohen, Adam F.;
    • van Poelgeest, Mariette I.;
    • Kenter, Gemma G.;
    • Kroep, Judith R.;
    • Burggraaf, Jacobus;
    • Melief, Cornelis J.;
    • van der Burg, Sjoerd H.
    Publication type:
    Article